- Datum06.05.2024
- Uhrzeit15:00 - 16:00 Uhr
- VeranstalterLYNX
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnenFusion Pharmaceuticals Inc. Registered Shares o.N. Kurse
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
Nasdaq | VK | |||||
Nasdaq Basic | VK | |||||
Cboe BZX | VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (Nasdaq)
Wikifolio
Passender Service zu Fusion Pharmaceuticals Inc. Registered Shares o.N.
Webinar zu Fusion Pharmaceuticals Inc. Registered Shares o.N.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)2,310-21,580
- Jahrestief / Hoch ($)7,590-21,580
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Fusion Pharmaceuticals Inc. Registered Shares o.N.
Termine von Fusion Pharmaceuticals Inc. Registered Shares o.N.
Beschreibung
Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company's focus is on the development of next-generation radiopharmaceuticals as precision medicines for hard-to-treat cancers. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm's lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others.